Menu Back to Event-Details

Making Clinical Trial Information Accessible: Experiences in Developing Informed Consent Forms and Lay Summaries of Study Results

Track:
What Can Stakeholders Expect from Clinical Trial (Development), Transparency and Medical Information?

Day & Time:
April 19, 8:30AM - 10:00AM (Central Europe Standard Time)

Session Number:
S0604

Type:
Session

Title:
Making Clinical Trial Information Accessible: Experiences in Developing Informed Consent Forms and Lay Summaries of Study Results

Chair(s):
D.K.Theo Raynor, PhD, MPharm
Professor of Pharmacy Practice
University of Leeds, United Kingdom

Thomas M. Schindler, PhD
Head Medical Writing Europe
Boehringer Ingelheim Pharma GmbH & Co.KG, Germany

Description:
Making Clinical Trial Information Accessible: Experiences in Developing Informed Consent Forms and Lay Summaries of Study Results

Presentation(s) & Speaker(s):
Applying User Involvement and User Testing to Improved Consent Forms - The Process and Findings
D.K.Theo Raynor, PhD, MPharm
Professor of Pharmacy Practice
University of Leeds, United Kingdom

Developing a Company-Wide Strategy for Improving and Implementing
Jan Lynge
Head of Clinical Pharmacology
Novo Nordisk A/S, Denmark

Challenges and Solutions in the Writing of Lay Summaries of Study Results
Kamila Sroka-Saidi
Senior Medical Writer
Boehringer Ingelheim GmbH and Co. KG, Germany

Company-Wide Implementation of a Lay Summary Process – Do’s and Don’ts
Thomas M. Schindler, PhD
Head Medical Writing Europe
Boehringer Ingelheim Pharma GmbH & Co.KG, Germany